AR026704A1 - Forma cristalina - Google Patents
Forma cristalinaInfo
- Publication number
- AR026704A1 AR026704A1 ARP000106383A ARP000106383A AR026704A1 AR 026704 A1 AR026704 A1 AR 026704A1 AR P000106383 A ARP000106383 A AR P000106383A AR P000106383 A ARP000106383 A AR P000106383A AR 026704 A1 AR026704 A1 AR 026704A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- refers
- pharmaceutically acceptable
- crystalline form
- solvate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000012453 solvate Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000030159 metabolic disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 4-tert-butoxycarbonylaminophenyl Chemical group 0.000 abstract 1
- 208000031773 Insulin resistance syndrome Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a las formas cristalinas del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi}fenil}-(S)-2-etoxi propanoico, segunformula (1) o su sal farmacéuticamente aceptable, y cualquiera de sus solvatos. La presente también se refiere a los métodos para tratar una o más enfermedadesmetabolicas, particularmente aquellas asociadas con el Síndrome de Resistencia a la Insulina, y el uso de la forma cristalina del compuesto, o su salfarmacéuticamente aceptable, o su solvato , para la fabricacion de un medicamento para uso terapéutico en una o más enfermedades metabolicas. La presente ademásse refiere a las composiciones farmacéuticas que contienen a la forma cristalina del compuesto, o su sal farmacéuticamente aceptable , o su solvato, comoingrediente activo, así como también a los procesos para la fabricacion de la forma cristalina del compuesto, o su sal farmacéuticamente aceptable, o susolvato.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904417A SE9904417D0 (sv) | 1999-12-03 | 1999-12-03 | Crystalline form |
| SE0001422A SE0001422D0 (sv) | 2000-04-17 | 2000-04-17 | Crystalline form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026704A1 true AR026704A1 (es) | 2003-02-26 |
Family
ID=26655079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106383A AR026704A1 (es) | 1999-12-03 | 2000-12-01 | Forma cristalina |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR026704A1 (es) |
| AU (1) | AU2034601A (es) |
| WO (1) | WO2001040165A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| CN100376560C (zh) | 1997-10-27 | 2008-03-26 | 雷迪实验室有限公司 | 新型三环化合物和其作为药物的用途;其制备方法和包含该化合物的药物组合物 |
| CN1280574A (zh) | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
| RU2247722C2 (ru) | 1997-10-27 | 2005-03-10 | Др. Редди`З Лабораториз Лимитед | Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| PL347208A1 (en) | 1998-10-29 | 2002-03-25 | Reddy S Res Fundation Dr | An improved process for the preparation of new antidiabetic agents |
| US6897199B2 (en) | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
-
2000
- 2000-11-29 WO PCT/SE2000/002379 patent/WO2001040165A1/en not_active Ceased
- 2000-11-29 AU AU20346/01A patent/AU2034601A/en not_active Abandoned
- 2000-12-01 AR ARP000106383A patent/AR026704A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001040165A1 (en) | 2001-06-07 |
| AU2034601A (en) | 2001-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029412A1 (es) | Forma cristalina | |
| ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
| CL2004000382A1 (es) | Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6. | |
| ECSP055774A (es) | Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica | |
| AR077478A2 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
| ECSP066950A (es) | Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2 | |
| BRPI0513864A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades | |
| AR057712A1 (es) | Dihidropteridinonas en el tratamiento de enfermedades respiratorias | |
| UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
| AR029211A1 (es) | Derivados de oxazoles, el uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los comprenden | |
| SE0401342D0 (sv) | Therapeutic compounds | |
| AR029456A1 (es) | Forma triturada | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| AR056575A1 (es) | Compuesto de (alfa)-aminocarboxiamida que es 5-(4-[[(2-fluorofenil) metil] oxi] fenil)prolinamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y proceso para prepararlo | |
| AR043822A1 (es) | Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr | |
| ATE331711T1 (de) | Entzündungshemmende 3-arylthio-3- thiazolylalkylamine | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| AR026704A1 (es) | Forma cristalina | |
| UY27959A1 (es) | Nuevos agonistas ppar alfa y ppar gama | |
| AR001769A1 (es) | Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación | |
| AR026705A1 (es) | Forma triturada | |
| UY27074A1 (es) | Derivados de aminotriazolopiridina | |
| PE20030277A1 (es) | Composicion farmaceutica que comprende 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y l-dopa | |
| AR106180A2 (es) | COMPUESTO DE a-AMINOCARBOXIAMIDA QUE ES 5-(4-{[(2-FLUOROFENIL)METIL]OXI}FENIL)PROLINAMIDA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |